Other studies show that MYC activates angiogenesis by increasing the expression of Interleukin 1β and VEGF and suppressing Thrombospondin-1 (TSP-1), thereby facilitating the delivery of nutrients to cancer cells and allowing for the escape of cancer cells into the bloodstream [14,98,99]. Here, VEGFA is linked to cancer.